Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease
Authors:
- Marisol LópezMLMarisol López
- Nancy MonroyNancy Monroy
- Marie-Catherine BollMBMarie-Catherine Boll
- Mayela Rodríguez-ViolanteMRMayela Rodríguez-Violante
- Adriana OchoaAOAdriana Ochoa
- María Elisa AlonsoMAMaría Elisa Alonso
- 1 November 2010
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 485 (2) , 79-82
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Parkinson's disease: from monogenic forms to genetic susceptibility factorsHuman Molecular Genetics, 2009
- LRRK2 G2019S and R1441G mutations associated with Parkinson’s disease are common in the Basque Country, but relative prevalence is determined by ethnicityneurogenetics, 2008
- The Gly2019Ser mutation in LRRK2is not fully penetrant in familial Parkinson's disease: the GenePD studyBMC Medicine, 2008
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyThe Lancet Neurology, 2008
- Leucine‐rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarianMovement Disorders, 2006
- Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*Brain, 2005
- An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 familyAnnals of Neurology, 2005
- Genetic admixture of European FRDA genes is the cause of Friedreich ataxia in the Mexican populationGenomics, 2004
- The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder serviceBrain, 2002